Michael Gottlieb

Corporate Officer/Principal en POINT Biopharma, Inc. (United States) .

45 años

Health Technology

Consumer Services

Commercial Services

Perfil

Michael Gottlieb is currently the Chief Commercial Officer at POINT Biopharma, Inc. in the United States.
Prior to this, he worked at Sanofi Canada, Inc. as the Head of Rare Diseases Franchise from 2017 to 2019.
He also briefly served as the Chief Commercial Officer at POINT Biopharma Global, Inc. in 2021.
Mr. Gottlieb has a graduate degree from the University of Toronto and an undergraduate degree from the University of Western Ontario.

Cargos activos de Michael Gottlieb

Empresas	Cargo	Inicio
POINT Biopharma, Inc. (United States) POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.	Corporate Officer/Principal	01/01/2020

Todos los cargos activos de Michael Gottlieb

Antiguos cargos conocidos de Michael Gottlieb.

Empresas	Cargo	Fin
POIT BIOP	Corporate Officer/Principal	25/11/2021
Sanofi Canada, Inc. Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada.	Corporate Officer/Principal	01/09/2019

Ver el detalle de la experiencia de Michael Gottlieb.

Formación de Michael Gottlieb.

University of Western Ontario	Undergraduate Degree
University of Toronto	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Gottlieb.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
POIT BIOP	Health Technology

Empresas privadas	2
POINT Biopharma, Inc. (United States) POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.	Commercial Services
Sanofi Canada, Inc. Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada.	Health Technology